Chief Business Officer
Orly Mishan has served as our Chief Business Officer since July 2019
Previously, Ms. Mishan served as a principal at Bain Capital Life Sciences, where she was responsible for overseeing investments in biopharmaceutical, medical device, diagnostics and enabling technology companies.
Prior to joining Bain Capital Life Sciences, Ms. Mishan held roles of increasing responsibility at Biogen Inc., most recently as the vice president of corporate strategy. Prior to joining Biogen, she held various leadership positions during her 10-year tenure at Boston Scientific, most recently as director, global healthcare solutions. She began her career as a business analyst at McKinsey & Company and transitioned to a role in the healthcare industry at Pfizer Pharmaceuticals.
Ms. Mishan is an advisor to Bain Capital Life Sciences, and a member of the board of directors of Kestra Medical Technologies. She earned a B.A. in economics and political science from Columbia University.